The pharmaceutical company citied promising pipeline developments and said cancer treatments drove above-expected growth.

F5, Inc.'s Q1 results showed strong revenue and margin performance, with notable competitive wins. Read why I remain bullish on FFIV stock.

US Dollar slides as China retaliates with fresh tariffs, raising market volatility. GBP/USD and EUR/USD show bullish ...

Toyota Motor raised its full-year operating profit forecast by 9% on Wednesday, in a sign of confidence in its ability to ...

Toyota Motor raised its full-year operating profit forecast by 9% on Wednesday, in a sign of confidence in its ability to ...

EA confirmed weak results for its latest quarterly earnings, mainly attributed to a rough start for "Dragon Age: The ...

The outfield position has a wide range of different skill sets. The best options offer winning stats in five categories. Unfortunately, the inventory is short i ...

Tim Connelly has been one of the most aggressive dealmakers in the NBA since he arrived in Minnesota three seasons ago.

Merck posted Q4 sales of $15.62 billion, driven by Keytruda's 19% growth. FY25 guidance lags estimates, citing Gardasil ...

(Reuters) - Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for ...

Read here for an analysis of backlog data and investment potential for Brookfield Infrastructure Partners. See why we rate ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...